MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- Indian - pharmaceuticals
- PIRAMAL ENTERPRISES - TRANSPEK FIN
PIRAMAL ENTERPRISES vs TRANSPEK FIN - Comparison Results
Current Valuations
| PIRAMAL ENTERPRISES | TRANSPEK FIN | PIRAMAL ENTERPRISES/ TRANSPEK FIN |
|||
|---|---|---|---|---|---|
| P/E (TTM) | x | -9.5 | 10.9 | - | View Chart |
| P/BV | x | 0.7 | 2.4 | 27.7% | View Chart |
| Dividend Yield | % | 3.4 | 0.0 | - |
Financials
 PIRAMAL ENTERPRISES  TRANSPEK FIN |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| PIRAMAL ENTERPRISES Mar-23 |
TRANSPEK FIN Mar-23 |
PIRAMAL ENTERPRISES/ TRANSPEK FIN |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 2,385 | 100 | 2,392.1% | |
| Low | Rs | 630 | 26 | 2,391.7% | |
| Income per share (Unadj.) | Rs | 374.4 | 134.3 | 278.8% | |
| Earnings per share (Unadj.) | Rs | 417.7 | 6.1 | 6,893.8% | |
| Cash flow per share (Unadj.) | Rs | 591.2 | 126.4 | 467.6% | |
| Dividends per share (Unadj.) | Rs | 31.00 | 0 | - | |
| Avg Dividend yield | % | 2.1 | 0 | - | |
| Book value per share (Unadj.) | Rs | 1,301.4 | 41.4 | 3,140.0% | |
| Shares outstanding (eoy) | m | 238.66 | 7.47 | 3,194.9% | |
| Bonus / Rights / Conversions | 0 | 0 | - | ||
| Avg Price / Income ratio | x | 4.0 | 0.5 | 857.6% | |
| Avg P/E ratio | x | 3.6 | 10.4 | 34.7% | |
| Avg P/CF ratio | x | 3.5 | 7.7 | 45.8% | |
| Avg Price/Bookvalue ratio | x | 1.2 | 1.5 | 76.2% | |
| Dividend payout | % | 7.4 | 0 | - | |
| Avg Mkt Cap | Rs m | 359,797 | 471 | 76,399.4% | |
| No. of employees | `000 | NA | NA | - | |
| Total wages & salary | Rs m | 9,301 | 45 | 20,834.5% | |
| Avg. income/employee | Rs Th | 0 | 0 | - | |
| Avg. wages/employee | Rs Th | 0 | 0 | - | |
| Avg. net profit/employee | Rs Th | 0 | 0 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Interest income | Rs m | 89,343 | 1,003 | 8,908.7% | |
| Other income | Rs m | 11,602 | 15 | 75,732.4% | |
| Interest expense | Rs m | 40,412 | 16 | 249,455.6% | |
| Net interest income | Rs m | 48,931 | 987 | 4,959.2% | |
| Operating expense | Rs m | 83,948 | 909 | 9,233.3% | |
| Gross profit | Rs m | -35,017 | 77 | -45,194.6% | |
| Gross profit margin | % | -39.2 | 7.7 | -507.3% | |
| Provisions/contingencies | Rs m | 2,749 | 16 | 16,960.5% | |
| Profit before tax | Rs m | 59,905 | 80 | 74,788.1% | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Minority Interest | Rs m | 0 | -29 | -0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Tax | Rs m | -39,781 | 6 | -642,657.5% | |
| Profit after tax | Rs m | 99,686 | 45 | 220,251.4% | |
| Net profit margin | % | 111.6 | 4.5 | 2,472.3% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Advances | Rs m | 0 | 0 | - | |
| Deposits | Rs m | 0 | 0 | - | |
| Credit/Deposit ratio | x | 0 | 0 | - | |
| Yield on advances | % | 0 | 0 | - | |
| Cost of deposits | % | 0 | 0 | - | |
| Net Interest Margin | % | 16.5 | 32,456.3 | 0.1% | |
| Net fixed assets | Rs m | 9,525 | 86 | 11,033.4% | |
| Share capital | Rs m | 477 | 75 | 638.8% | |
| Free reserves | Rs m | 310,113 | 235 | 132,030.3% | |
| Net worth | Rs m | 310,590 | 310 | 100,319.8% | |
| Borrowings | Rs m | 34,126 | 44 | 77,805.5% | |
| Investments | Rs m | 296,427 | 3 | 9,750,894.7% | |
| Total assets | Rs m | 895,367 | 845 | 105,993.3% | |
| Debt/equity ratio | x | 0.1 | 0.2 | 44.2% | |
| Return on assets | % | 11.1 | 5.4 | 207.8% | |
| Return on equity | % | 32.1 | 14.6 | 219.5% | |
| Capital adequacy ratio | % | 43.6 | 0 | - | |
| Net NPAs | % | 2.3 | 0 | - | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 13,593 | -9 | -155,530.9% | |
| From Investments | Rs m | -3,512 | -20 | 17,984.6% | |
| From Financial Activity | Rs m | -33,245 | 42 | -78,612.7% | |
| Net Cashflow | Rs m | -23,164 | 14 | -165,105.5% | |
Share Holding
| Indian Promoters | % | 46.2 | 53.9 | 85.7% | |
| Foreign collaborators | % | 0.0 | 0.0 | - | |
| Indian inst/Mut Fund | % | 30.2 | 0.0 | - | |
| FIIs | % | 17.0 | 0.0 | - | |
| ADR/GDR | % | 0.0 | 0.0 | - | |
| Free float | % | 53.8 | 46.1 | 116.7% | |
| Shareholders | 315,945 | 2,950 | 10,710.0% | ||
| Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PIRAMAL ENTERPRISES With: BAJAJ FINANCE BAJAJ HOLDINGS & INVESTMENT CHOLAMANDALAM INVEST SBI CARDS TATA INVESTMENT
More on Piramal Enterprises vs TRANSPEK FIN
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Piramal Enterprises vs TRANSPEK FIN Share Price Performance
| Period | Piramal Enterprises | TRANSPEK FIN | S&P BSE HEALTHCARE |
|---|---|---|---|
| 1-Day | 1.90% | 3.05% | 0.45% |
| 1-Month | 7.73% | 4.17% | 2.55% |
| 1-Year | 28.98% | 29.49% | 56.14% |
| 3-Year CAGR | -17.30% | 62.60% | 15.22% |
| 5-Year CAGR | -17.03% | 44.26% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Piramal Enterprises share price and the TRANSPEK FIN share price.
Moving on to shareholding structures...
The promoters of Piramal Enterprises hold a 46.2% stake in the company. In case of TRANSPEK FIN the stake stands at 53.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Piramal Enterprises and the shareholding pattern of TRANSPEK FIN.
Finally, a word on dividends...
In the most recent financial year, Piramal Enterprises paid a dividend of Rs 31.0 per share. This amounted to a Dividend Payout ratio of 7.4%.
TRANSPEK FIN paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Piramal Enterprises, and the dividend history of TRANSPEK FIN.
For a sector overview, read our pharmaceuticals sector report.
Today's Market
![Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%]()
Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.